相关实验视频
Updated: Jul 29, 2026

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
非洲毒素B1通过小鼠肠道微生物群诱导炎症性肝损伤
Lin Ye1, Huodai Chen1, Karl Wah Keung Tsim2
1Guangdong Provincial Key Laboratory of Food Quality and Safety/National-Local Joint Engineering Research Center for Machining and Safety of Livestock and Poultry Products, South China Agricultural University, Guangzhou 510642, China.
Journal of agricultural and food chemistry
|July 5, 2023
概括
阿弗拉托克素B1暴露会改变肠道微生物群,导致结肠屏障功能障碍和肝炎. 消耗肠道微生物可以防止这些影响,这表明微生物群.
科学领域:
- 毒理学 毒理学 毒理学
- 微生物学 微生物学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 非洲毒素B1 (AFB1) 是一种强大的食源性肝癌原体.
- 对亚毒素的特定物种敏感性并不能完全由代谢解释.
- 肠道微生物群在AFB1诱导的肝损伤中的作用尚不清楚.
研究的目的:
- 调查肠道微生物群在AFB1诱导的肝损伤中的作用.
- 分析AFB1对肠道微生物群,结肠屏障和肝炎的影响.
- 确定肠道微生物群是否直接导致AFB1肝毒性.
主要方法:
- 在28天的时间里,小鼠接受了AFB1的输入.
- 分析了肠道微生物群,结肠屏障和肝炎.
- 使用抗生素混合物 (ABX) 和便微生物群移植 (FMT) 来操纵肠道微生物群.
主要成果:
- AFB1改变了肠道微生物群的组成,增加了特定的细菌丰度.
- AFB1诱导结肠屏障功能障碍和肝炎.
- 与ABXs一起的微生物群枯竭减轻了AFB1对结肠和肝脏的影响.
- 来自AFB1治疗小鼠的微生物群的FMT诱导了结肠和肝脏病理.
结论:
- 肠道微生物群直接参与AFB1诱导的肝炎和炎症.
- 这些发现为AFB1肝毒性机制提供了新的见解.
- 针对肠道微生物群的有针对性的干预措施可以预防或减少AFB1毒性.
更多相关视频
相关概念视频
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Gut-Brain Axis
The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such as...
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

